Malmoe Lp-PLA2 study - association with metabolic syndrome

被引:0
|
作者
Persson, M. [1 ]
Hedblad, B. [1 ]
Nelson, J. J. [1 ]
Berglund, G. [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:106 / 106
页数:1
相关论文
共 50 条
  • [21] Lp-PLA2: A New Target for Statin Therapy
    Braun, Lynne T.
    Davidson, Michael H.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 29 - 33
  • [22] Novel enzymatic method for assaying Lp-PLA2
    Yamaura, S.
    Sakasegawa, S.
    Ueda, S.
    Kayamori, Y.
    Sugimori, D.
    Karasawa, K.
    CLINICA CHIMICA ACTA, 2019, 493 : S190 - S191
  • [23] Lp-PLA2: A New Target for Statin Therapy
    Lynne T. Braun
    Michael H. Davidson
    Current Atherosclerosis Reports, 2010, 12 : 29 - 33
  • [24] Lp-PLA2 and risk of atherosclerotic vascular disease
    Rosenson, Robert S.
    LANCET, 2010, 375 (9725): : 1498 - 1500
  • [25] Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events
    Steen D.L.
    O'Donoghue M.L.
    Cardiology and Therapy, 2013, 2 (2) : 125 - 134
  • [26] Lp-PLA2:: A new marker of vascular risk
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1167): : 83 - 83
  • [27] Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population
    Enkhmaa, Byambaa
    Anuurad, Erdembileg
    Zhang, Wei
    Pearson, Thomas A.
    Berglund, Lars
    ATHEROSCLEROSIS, 2010, 211 (02) : 526 - 530
  • [28] Lp-PLA2 and sPLA2: cardiovascular biomarkers
    Ait-Oufella, Hafid
    Mallat, Ziad
    Tedgui, Alain
    M S-MEDECINE SCIENCES, 2014, 30 (05): : 526 - 531
  • [29] Association of Lp-PLA2 activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome
    Chae, Jey Sook
    Kim, Oh Yoen
    Paik, Jean Kyung
    Kang, Ryungwoo
    Seo, Woo Ju
    Jeong, Tae-Sook
    Sweeney, Gary
    Lee, Sang-Hyun
    Lee, Jong Ho
    ATHEROSCLEROSIS, 2011, 218 (02) : 499 - 506
  • [30] Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2 and risk of coronary heart disease. Results from a large case-control study
    Khuseyinova, N.
    Rothenbacher, D.
    Hoffmann, M.
    Brenner, H.
    Koenig, W.
    EUROPEAN HEART JOURNAL, 2006, 27 : 129 - 129